PHAR vs REGN: Which Stock is Better?
Side-by-side comparison of Pharming Group Nv and Regeneron Pharmaceuticals Inc in 2026
PHAR
Pharming Group Nv
$17.34
REGN
Regeneron Pharmaceuticals Inc
$750.57
Key Metrics Comparison
| Metric | PHAR | REGN | Winner |
|---|---|---|---|
| Market Cap | $1.22B | $79.35B | REGN |
| P/E Ratio | 433.50 | 18.08 | REGN |
| EPS (TTM) | $0.04 | $41.51 | REGN |
| Revenue Growth | 0.1% | 0.0% | PHAR |
| Gross Margin | 87.9% | 44.6% | PHAR |
Analyze PHAR
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHAR or REGN a better investment?
Comparing PHAR and REGN: Pharming Group Nv has a market cap of $1.22B while Regeneron Pharmaceuticals Inc has $79.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHAR and REGN?
PHAR (Pharming Group Nv) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHAR or REGN?
Based on P/E ratios, REGN trades at a lower multiple (18.1x vs 433.5x).
Which is growing faster: PHAR or REGN?
PHAR has higher revenue growth at 0.1% vs 0.0% for REGN.
Which company is more profitable: PHAR or REGN?
Pharming Group Nv (PHAR) has higher gross margins at 87.9% compared to 44.6% for REGN.
Which is the larger company: PHAR or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.35B compared to $1.22B for PHAR.
Should I buy PHAR or REGN in 2026?
Both PHAR and REGN have investment merit. PHAR trades at $17.34 while REGN trades at $750.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHAR and REGN stock?
Key differences: Market Cap ($1.22B vs $79.35B), P/E Ratio (433.5x vs 18.1x), Revenue Growth (0.1% vs 0.0%), Gross Margin (87.9% vs 44.6%).